https://www.selleckchem.com/pr....oducts/ly2835219.htm
INTRODUCTION We aimed to validate the HERDOO2, DASH and Updated Vienna recurrent venous thromboembolism prediction models in a population composed entirely of first unprovoked pulmonary embolism and analyzed the impact of the addition of pulmonary vascular obstruction index (PVOI) on score accuracy. METHODS Analyses were based on the double-blind randomized "PADIS-PE" trial including 371 unprovoked pulmonary embolism patients initially treated during 6 months, successively randomized to receive an additional 18-months of warfarin or p
Like
Comment
Share
